Literature DB >> 1721396

FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.

P B Carroll1, H Rilo, J Reyes, R Alejandro, Y Zeng, C Ricordi, A Tzakis, R Shapiro, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721396      PMCID： PMC2954633     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics of FK 506: preclinical and clinical studies.

Authors:  R Venkataramanan; A Jain; E Cadoff; V Warty; K Iwasaki; K Nagase; A Krajack; O Imventarza; S Todo; J J Fung
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Oral glucose tolerance test in liver recipients treated with FK 506.

Authors:  L Mieles; S Todo; J J Fung; A Jain; H Furukawa; M Susuki; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  In vitro effects of FK-506 on human and rat islets.

Authors:  W J Tze; J Tai; S Cheung
Journal:  Transplantation       Date:  1990-06       Impact factor: 4.939

4.  Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans.

Authors:  P B Carroll; A C Boschero; M Y Li; A G Tzakis; T E Starzl; I Atwater
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

5.  Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.

Authors:  L Mieles; R D Gordon; D Mintz; R M Toussaint; O Imventarza; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

Authors:  A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

7.  Kidney transplantation in the dog receiving FK-506.

Authors:  D S Collier; S Thiru; R Calne
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

8.  Toxicity of FK-506 in human fetal pancreas.

Authors:  D K Leonard; A S Landry; H W Sollinger; D A Hullett
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

9.  The effect of FK 506 on canine pancreatic islet cell function in beagle dogs.

Authors:  S Strasser; R Alejandro; C Ricordi; S Todo; D H Mintz
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066
  9 in total
  10 in total

1.  Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.

Authors:  O Odocha; J McCauley; V Scantlebury; R Shapiro; P Carroll; M Jordan; C Vivas; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

2.  Long-term insulin requirement after liver transplantation with FK 506 in American veterans.

Authors:  J Tabasco-Minguillan; L Mieles; P Carroll; J Gavaler; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

3.  Two-year experience with FK 506 in pediatric patients.

Authors:  A G Tzakis; J Reyes; S Todo; B Nour; R Shapiro; M Jordan; J McCauley; J Armitage; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

4.  Pediatric renal transplantation under tacrolimus-based immunosuppression.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; D Ellis; S Lombardozzi-Lane; N Gilboa; H A Gritsch; W Irish; J McCauley; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplantation       Date:  1999-01-27       Impact factor: 4.939

Review 5.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12

Review 6.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 7.  Clinical use of tacrolimus (FK-506) in infants and children with renal transplants.

Authors:  D Ellis
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

8.  Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.

Authors:  S Furth; A Neu; P Colombani; L Plotnick; M E Turner; B Fivush
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

Review 9.  The role of environmental factors in insulin-dependent diabetes mellitus: an unresolved issue.

Authors:  M R Kraine; R M Tisch
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

10.  Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients.

Authors:  Rahul Chanchlani; Sang Joseph Kim; Esther D Kim; Tonny Banh; Karlota Borges; Jovanka Vasilevska-Ristovska; Yanhong Li; Vicky Ng; Anne I Dipchand; Melinda Solomon; Diane Hebert; Rulan S Parekh
Journal:  Nephrol Dial Transplant       Date:  2017-09-01       Impact factor: 5.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.